175 related articles for article (PubMed ID: 30099334)
1. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
4. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene.
Frederiksen HR; Holst B; Ramakrishna S; Muddashetty R; Schmid B; Freude K
Stem Cell Res; 2019 Jan; 34():101368. PubMed ID: 30634129
[TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
6. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
[TBL] [Abstract][Full Text] [Related]
8. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
9. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
[TBL] [Abstract][Full Text] [Related]
11. The effects of different familial Alzheimer's disease mutations on APP processing in vivo.
Thordardottir S; Kinhult Ståhlbom A; Almkvist O; Thonberg H; Eriksdotter M; Zetterberg H; Blennow K; Graff C
Alzheimers Res Ther; 2017 Feb; 9(1):9. PubMed ID: 28209190
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
[TBL] [Abstract][Full Text] [Related]
13. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
[TBL] [Abstract][Full Text] [Related]
14. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
15. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
16. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
18. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
[TBL] [Abstract][Full Text] [Related]
20. Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I).
Hernández D; Morgan Schlicht S; Daniszewski M; Karch CM; ; Goate AM; Pébay A
Stem Cell Res; 2021 May; 53():102373. PubMed ID: 34088002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
